Reuters logo
BRIEF-Aclaris Therapeutics announces issuance of new U.S. Patent for A-101 topical solutions
June 13, 2017 / 12:20 PM / 3 months ago

BRIEF-Aclaris Therapeutics announces issuance of new U.S. Patent for A-101 topical solutions

June 13 (Reuters) - Aclaris Therapeutics Inc-

* Aclaris Therapeutics announces issuance of new U.S. Patent for a-101 topical solutions

* Aclaris Therapeutics Inc says patent contains 70 claims and expires in july 2035 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below